AU2001260413A1 - Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses - Google Patents
Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic usesInfo
- Publication number
- AU2001260413A1 AU2001260413A1 AU2001260413A AU6041301A AU2001260413A1 AU 2001260413 A1 AU2001260413 A1 AU 2001260413A1 AU 2001260413 A AU2001260413 A AU 2001260413A AU 6041301 A AU6041301 A AU 6041301A AU 2001260413 A1 AU2001260413 A1 AU 2001260413A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- fragments
- polynucleotides encoding
- therapeutic uses
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001184 polypeptide Polymers 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 239000012634 fragment Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006030A FR2808801B1 (en) | 2000-05-11 | 2000-05-11 | POLYPEPTIDE RH116 AND ITS FRAGMENTS AND POLYNUCLEOTIDES ENCODING SAID POLYPEPTIDES AND THERAPEUTIC APPLICATIONS |
FR0006030 | 2000-05-11 | ||
PCT/FR2001/001441 WO2001085955A1 (en) | 2000-05-11 | 2001-05-11 | Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001260413A1 true AU2001260413A1 (en) | 2001-11-20 |
Family
ID=8850126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001260413A Abandoned AU2001260413A1 (en) | 2000-05-11 | 2001-05-11 | Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040086500A1 (en) |
EP (1) | EP1285074A1 (en) |
JP (1) | JP2003532424A (en) |
AU (1) | AU2001260413A1 (en) |
CA (1) | CA2408576A1 (en) |
FR (1) | FR2808801B1 (en) |
WO (1) | WO2001085955A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7229822B1 (en) * | 2000-02-29 | 2007-06-12 | Univ Columbia | Melanoma differentation associated gene-5 and vectors and cells containing same |
MX2007006252A (en) * | 2004-11-24 | 2009-02-13 | Theraptosis Sa | New peptides useful as dual caspase-2/-6 inhibitors and their biological applications. |
CN101805770B (en) * | 2010-03-12 | 2012-10-31 | 南京工业大学 | Method for producing cyclic adenosine monophosphate by whole-cell biocatalysis |
FR2987627B1 (en) | 2012-03-05 | 2016-03-18 | Splicos | USE OF RBM39 AS A BIOMARKER |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19545126A1 (en) * | 1995-12-04 | 1997-06-05 | Hoechst Ag | ATP and nucleic acid binding protein with helicase properties |
US5888792A (en) * | 1997-07-11 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | ATP-dependent RNA helicase protein |
AU7126700A (en) * | 1999-09-08 | 2001-04-10 | Biogen, Inc. | Novel interferon induced polynucleotides and proteins encoded thereby |
US7229822B1 (en) * | 2000-02-29 | 2007-06-12 | Univ Columbia | Melanoma differentation associated gene-5 and vectors and cells containing same |
-
2000
- 2000-05-11 FR FR0006030A patent/FR2808801B1/en not_active Expired - Fee Related
-
2001
- 2001-05-11 JP JP2001582544A patent/JP2003532424A/en active Pending
- 2001-05-11 AU AU2001260413A patent/AU2001260413A1/en not_active Abandoned
- 2001-05-11 US US10/275,822 patent/US20040086500A1/en not_active Abandoned
- 2001-05-11 CA CA002408576A patent/CA2408576A1/en not_active Abandoned
- 2001-05-11 EP EP01934104A patent/EP1285074A1/en not_active Withdrawn
- 2001-05-11 WO PCT/FR2001/001441 patent/WO2001085955A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2808801A1 (en) | 2001-11-16 |
EP1285074A1 (en) | 2003-02-26 |
FR2808801B1 (en) | 2004-10-08 |
WO2001085955A1 (en) | 2001-11-15 |
US20040086500A1 (en) | 2004-05-06 |
CA2408576A1 (en) | 2001-11-15 |
JP2003532424A (en) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1568773A2 (en) | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | |
AUPR497101A0 (en) | Polynucleotides and polypeptides linked to cancer and/or tumorigenesi | |
AU2001263105A1 (en) | Human semaphorin homologs and polynucleotides encoding the same | |
AUPQ976800A0 (en) | Novel polypeptides and polynucleotides and uses therefor | |
AU2001265009A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
AU2225000A (en) | Sequence-determined dna fragments and corresponding polypeptides encoded thereby | |
IL153568A (en) | Novel polypeptides and polynucleotides | |
IL160229A0 (en) | Polynucleotides, polypeptides encoded thereby and their use | |
AU2001280608A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
AU5586500A (en) | Human sel-10 polypeptides and polynucleotides that encode them | |
AU2002330672A1 (en) | Gmg-1 polynucleotides and polypeptides and uses thereof | |
AU2001240075A1 (en) | Full length expressed polynucleotides and the polypeptides they encode | |
AU2002327676A1 (en) | Novel polynucleotides and proteins encoded thereby | |
AU2001260413A1 (en) | Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses | |
AU2002303284A1 (en) | Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides | |
AU2001280464A1 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
AU2001239378A1 (en) | Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses | |
AU2001255832A1 (en) | Orfx polynucleotides and polypeptides | |
AU2002318186A1 (en) | Novel human kielin-like proteins and polynucleotides encoding the same | |
WO2002072611A8 (en) | Novel human egf-family proteins and polynucleotides encoding the same | |
AU2002364431A1 (en) | Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof | |
AU2001285326A1 (en) | Human kinase proteins and polynucleotides encoding the same | |
AU2002227496A1 (en) | Polynucleotides and polypeptides | |
AU2001275337A1 (en) | Novel human transporter proteins and polynucleotides encoding the same | |
AU2001274923A1 (en) | Novel human thrombospondin-like proteins and polynucleotides encoding the same |